Related by context. Frequent words. (Click for all words.) 69 Presents Positive 67 Completes Enrollment 66 Initiates Phase 65 Pivotal Phase III 64 Drug Candidate 64 proteasome inhibitor 64 oncolytic viruses 64 humanized anti 63 ImmuneRegen BioSciences Inc. 63 liposomal formulation 63 CHEAP ONLINE PHARMACY LOW 63 non alcoholic steatohepatitis 63 Cetrorelix 63 FDA Accepts 63 Onalta 62 Panzem R 62 NASDAQ CRXL 62 Entereg R 62 Inc Therapeutic Competitors 62 Inc. Nasdaq IMGN 62 multi kinase inhibitor 62 Clinical Trial Results 62 THAT COULD CAUSE ACTUAL 62 orally bioavailable 62 Advancing Drugs 62 BY JASON THOMPSON 62 DEBT AND IDENTITY 62 ALN TTR# 61 R sorafenib tablets 61 SARMs 61 Small Molecule 61 commercializing therapeutic 61 novel orally administered 61 EXPRESSED OR IMPLIED 61 Patent Covering 61 Recombinant Human 61 Azixa 61 TH STAFF WRITER 61 PRICE GREAT DISCOUNT FREE 61 TLR9 agonist 61 CONTAINS FORWARD LOOKING STATEMENTS 61 THAT ARE SUBJECT TO 61 Tesetaxel 61 phase IIb clinical 61 investigational compounds 61 CHEAP ONLINE PHARMACY BEST 61 VERIFICATION OF THE 61 MEK inhibitor 61 Nexavar ® 61 BELIEFS PLANS EXPECTATIONS OR 61 BELIEVES THAT THE 61 R bortezomib 61 immunologic diseases 61 NovaBay Pharmaceuticals Inc. 61 BioMarin develops 61 Cyclacel Pharmaceuticals Inc. 61 Pivotal Trial 60 polymerase inhibitors 60 oncology indications 60 PUBLISHED RATINGS CRITERIA AND 60 RESULTS TO DIFFER 60 anticancer compound 60 anticancer compounds 60 Carfilzomib 60 pseudobulbar affect PBA 60 diabetic neuropathic pain 60 IT WILL CONTAIN 60 WHICH ARE NOT PURELY 60 CONTAIN FORWARD LOOKING STATEMENTS 60 myeloproliferative disorders 60 humanized monoclonal antibody 60 MATERIALLY FROM ANY FUTURE 60 Idera Pharmaceuticals 60 Vytorin combines 60 Tissue Repair Company 60 ARE SUBJECT TO 60 THE ISSUER IS AUTHORITATIVE 60 J Am Coll 60 Exploit collaboration 60 Milnacipran 60 INVESTORS ARE URGED TO 60 Announces Initiation 60 novel antibody therapeutics 60 IS FOR INFORMATIONAL 60 ALL SUCH REPRESENTATIONS AND 60 CERTAIN RISKS AND UNCERTAINTIES 59 immuno inflammatory diseases 59 BELIEFS PLANS EXPECTATIONS AND 59 INCLUDE ANY STATEMENTS REGARDING 59 INTENTIONS CONTAINED IN 59 RESULTS PERFORMANCE OR ACHIEVEMENTS 59 THE REPORTING 59 Report companiesandmarkets.com adds 59 topical anti infective 59 Factor VIIa 59 PRICES GREAT DISCOUNTS 59 THEY CONTAIN IMPORTANT INFORMATION 59 CORT # 59 human antibody therapeutics 59 ONLY THE ORIGINAL 59 THIS SITE AT